Question of the WeekQ:
My father is taking levadopa and carbidopa four times a day. I read that vitamin B5 (pantothenic ac…
Featured Creativity and Parkinson's Artist
View the Gallery:
Applying to the International Research Grants Program (IRGP)
This program is closed for the 2016 cycle.
The International Research Grants Program (IRGP) is designed to promote innovative research that has a high potential to significantly advance the knowledge of Parkinson's disease (PD) but little likelihood of securing funding through more traditional sources. By supporting novel, "high risk/high reward" research, the goal of the IRGP is to enable investigators to demonstrate the feasibility of their ideas while generating preliminary data necessary for the support of future funding.
IRGP awards provide a maximum of $75,000 in direct costs per year for two years, subject to review of first year progress.
Learn more about this program:
- Program Overview
- Application Instructions, Deadlines and Funding Dates
- Additional Questions?
At its core, research supported by the IRGP must be directly relevant to the treatment and/or understanding of Parkinson's disease. Successful IRGP projects are:
- novel research hypotheses of Parkinson's disease;
- inventive in terms of methodology or approach; and
- clinical, preclinical, or basic research proposals that will directly impact Parkinson's disease or its treatment.
IRGP awards provide a maximum of $75,000 in direct costs per year for two years, subject to review of first year progress. Research grants are now also eligible for an additional 10 percent in indirect costs.
The IRGP is open to both national and international applicants; specifically independent investigators possessing postdoctoral training or a medical degree, with clinical, preclinical or basic research proposals that will directly impact Parkinson's disease or its treatment. Preference will be given to scientists who are at an early stage in their professional careers.
Postdoctoral researchers/scientists and fellows are not eligible to apply for this program.
Investigators who receive funding from PDF may not receive funding for other projects supported by PDF during the same year, nor receive funding from other foundations or institutions for the same project during that year.
Application Instructions, Deadlines & Funding Dates
This program is closed for the 2015 cycle.
The application process at PDF is highly competitive and only five percent of all proposals receive funding. To make the process more efficient for both applicants and reviewers, we have transitioned to a two-step application. An applicant will be asked to initially submit a Letter of Intent (LOI). If selected by our reviewers, the applicant can proceed and submit a full proposal.
All applications must be submitted online through the PDF website at grants.pdf.org; no paper copies will be accepted. To be considered for funding, an applicant must typically submit the LOI in mid-November. Applicants who are invited to submit a full proposal will be notified of their status in December. The deadline for submitting a full proposal is typically in mid-February.
Applicants can review the previous year's application instructions and checklist document for further information.
Review & Decisions
All proposals for IRGP awards are peer-reviewed and competitively ranked based upon scientific merit and its impact upon Parkinson's disease. Final decisions are typically expected by mid-April.
First year funding will commence July 1 and end June 30 of the following year. Continued funding into the award's second year is subject to rigorous review of research during the first year.
In the event that funding is recommended and approved for an applicant, please be advised that any and all equipment budgeted in the proposal and purchased with funds provided by the PDF Grants Program will be the property of the sponsoring institution and will remain there in the event the investigator should leave said institution.
Applicants who successfully receive PDF funding for their research are required to identify the Parkinson's Disease Foundation as a source of support in all published works and presentations. A copy of such papers is to be forwarded to email@example.com.